BioCryst Pharma Stock (NASDAQ: BCRX) stock price, news, charts, stock research, profile.
You can purchase shares of BioCryst Pharma (NASDAQ:BCRX) through any online brokerage.
Other companies in BioCryst Pharma’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), 89bio (NASDAQ:ETNB), Centessa Pharmaceuticals (NASDAQ:CNTA), Arcutis Biotherapeutics (NASDAQ:ARQT) and Protagonist Therapeutics (NASDAQ:PTGX).
BioCryst Pharma has a consensus price target of $13.78.
The stock price for BioCryst Pharma (NASDAQ: BCRX) is $9.39 last updated February 20, 2025 at 4:00 PM EST.
There are no upcoming dividends for BioCryst Pharma.
BioCryst Pharma’s Q1 earnings are confirmed for Monday, May 5, 2025.
There is no upcoming split for BioCryst Pharma.
BioCryst Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.